| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Itafos Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$1.01 |
| 52 Week High | CA$1.13 |
| 52 Week Low | CA$0.63 |
| Beta | -0.95 |
| 11 Month Change | 0% |
| 3 Month Change | 15.43% |
| 1 Year Change | 20.24% |
| 33 Year Change | 14.12% |
| 5 Year Change | 28.66% |
| Change since IPO | -58.26% |
Recent News & Updates
Recent updates
Shareholder Returns
| 82E | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | 4.7% | 0.2% | -1.9% |
| 1Y | 20.2% | 14.7% | 12.3% |
Return vs Industry: 82E exceeded the German Chemicals industry which returned 14.7% over the past year.
Return vs Market: 82E exceeded the German Market which returned 12.8% over the past year.
Price Volatility
| 82E volatility | |
|---|---|
| 82E Average Weekly Movement | 7.4% |
| Chemicals Industry Average Movement | 4.9% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 82E's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 82E's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 417 | George Delaney | www.itafos.com |
Itafos Inc. operates as a phosphate and specialty fertilizer company. It operates through Conda, Arrais, and Development and Exploration segments. The company produces and sells monoammonium phosphate (MAP), MAP with micronutrients, superphosphoric acid, merchant grade phosphoric acid, ammonium polyphosphate, hydrofluorosilicic acid, direct application phosphate rock, single superphosphate (SSP), SSP with micronutrients, and sulfuric acid.
Itafos Inc. Fundamentals Summary
| 82E fundamental statistics | |
|---|---|
| Market cap | €204.94m |
| Earnings (TTM) | -€4.42m |
| Revenue (TTM) | €421.74m |
0.5x
P/S Ratio-45.5x
P/E RatioIs 82E overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 82E income statement (TTM) | |
|---|---|
| Revenue | US$462.90m |
| Cost of Revenue | US$348.46m |
| Gross Profit | US$114.44m |
| Other Expenses | US$119.29m |
| Earnings | -US$4.85m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.025 |
| Gross Margin | 24.72% |
| Net Profit Margin | -1.05% |
| Debt/Equity Ratio | 22.2% |
How did 82E perform over the long term?
See historical performance and comparison